Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07212101 · ClinicalTrials.gov registry record · NA

Sleep in Collegiate Baseball Players

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT07212101 is a NA study that has completed, run by Columbia University. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07212101, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Sleep is an essential biological function that impacts nearly every aspect of an athlete's physical and mental health. For athletes, the importance of high-quality sleep cannot be overstated, as it plays a critical role in performance, recovery, and overall well-being. Sleep supports muscle recovery by promoting protein synthesis and the release of growth hormones, essential for healing after intense physical exertion. Furthermore, adequate sleep is crucial for maintaining cognitive sharpness, decision-making abilities, and emotional regulation-all of which are necessary for optimal athletic performance. The study will assess both sleep quality and quantity in baseball players at Columbia University. These tools will help quantify key sleep metrics, including sleep duration, latency (the time it takes to fall asleep), and the number of awakenings during the night. Similarly, the study will analyze dietary patterns using the Automated Self-Administered 24-Hour Dietary Assessment (ASA24), tracking nutrient intake, meal timing, and the consumption of ultra-processed foods. These assessments will establish a baseline from which to measure improvement post-intervention. The intervention will focus on improving diet, time in bed, and light exposure to improve sleep, diet, and performance in collegiate baseball athletes.

Interventions

  • BEHAVIORAL Sleep and diet

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2025-09-16
Est. Completion 2025-10-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT07212101

The ClinicalTrials.gov registry entry for NCT07212101 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sleep and diet is the first listed.

NCT07212101 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07212101 about?

NCT07212101 is a clinical study titled "Sleep in Collegiate Baseball Players". Sleep is an essential biological function that impacts nearly every aspect of an athlete's physical and mental health. For athletes, the importance of high-quality sleep cannot be overstated, as it plays a critical role in performance, recovery, and overall well-being. Sleep supports muscle recovery...

What is the current status of trial NCT07212101?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2025-09-16. Estimated completion is 2025-10-31.

What interventions are being tested in trial NCT07212101?

The interventions under investigation include: Sleep and diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT07212101?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.